News
-
23.06.2009
Salvacyl®, developed by Debiopharm, is launched in two European countries - a new therapeutic avenue for the treatment of sexual deviations - -
18.06.2009
Debiopharm Group and Moffitt Cancer Center sign development and commercialisation agreement for small molecule Debio 0928 in early preclinical development for treatment of solid tumours - A novel drug with potential to block cancer cell proliferation
Home
| News & Events |
|
Welcome to Debiopharm Group’s News & Events Center, aimed to give you immediate access to timely and relevant information about our company. In this section you will find information on our press releases, our Awards, a calendar of events, a list of our publications and a pdf of our corporate brochure.
|



